Meros Investment Management LP Makes New $4.53 Million Investment in InfuSystem Holdings, Inc. $INFU

Meros Investment Management LP bought a new stake in InfuSystem Holdings, Inc. (NYSE:INFU) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 468,934 shares of the company’s stock, valued at approximately $4,525,213. Meros Investment Management LP owned approximately 2.32% of InfuSystem at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Quarry LP bought a new position in InfuSystem during the fourth quarter valued at $31,000. Raymond James Financial Inc. purchased a new stake in InfuSystem in the 2nd quarter valued at about $33,000. Virtu Financial LLC purchased a new position in InfuSystem in the fourth quarter valued at about $90,000. LPL Financial LLC acquired a new stake in shares of InfuSystem in the fourth quarter valued at approximately $92,000. Finally, Jane Street Group LLC purchased a new stake in InfuSystem during the first quarter valued at about $96,000. 71.13% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, B. Riley Financial reissued a “buy” rating and issued a $20.00 price target (up from $12.00) on shares of InfuSystem in a research note on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $16.67.

InfuSystem Price Performance

NYSE INFU traded down $0.05 on Friday, reaching $12.01. The company had a trading volume of 36,756 shares, compared to its average volume of 165,994. The firm’s 50 day moving average price is $10.42 and its 200 day moving average price is $9.65. InfuSystem Holdings, Inc. has a 12 month low of $7.29 and a 12 month high of $12.97. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $242.39 million, a PE ratio of 200.20 and a beta of 1.42.

InfuSystem declared that its Board of Directors has approved a share repurchase program on Tuesday, May 19th that permits the company to repurchase $20.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 10.2% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.